chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 17-JUL-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 14-AUG-2014,t he patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to unspecified number of patients of unknown age and gender. The reporter stated that improperly stored doses of RECOMBIVAX HB were administered to an unspecified number of patients. Pertinent medical history and concomitant medications were unspecified by reported. No adverse effects reported. The outcome of the events was unknown. No further information was provided. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 23-JUL-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 28-JUL-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: HPV4
Symptoms: Exposure during pregnancy, Pain in extremity, Wrong drug administered
Clinical narrative: This spontaneous prospective pregnancy report as received from a 35 year old female consumer regarding on herself with sulfa allergy. The patient became pregnant with Last Menstrual Period on 07-FEB-2014, Estimated date of Conception 21-FEB-2014 and Estimated Date of Delivery of 14-NOV-2014. On 19-AUG-2014, the patient was vaccinated with GARDASIL 1 single shot, intramuscular (dose, strength frequency and lot number were not reported) at her 28 weeks of pregnancy. Secondary and concomitant therapies were not reported. Patient reported that at her 28 week checkup (on 19-AUG-2014), she was schedule to receive DTAP vaccine but the nurse accidentally gave her GARDASIL. The patient reported that she feels fine aside from her arm that was feeling a little sore. The outcome of arm feeling a little sore was reported as recovered/resolved (in an unknown date of 2014). At the time of the report the patient was 30 weeks of gestation. It was reported that the patient sought unspecified medical attention. No treatment was given for the adverse events. No labs diagnostics were performed. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 23-JUN-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 13-AUG-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 38.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Body temperature increased, Fatigue, Influenza like illness, Pain, Pain in extremity
Clinical narrative: This spontaneous report as received from a consumer refers to a 38 year old female patient with colitis, suppressed immune system, allergy to FLAGYL, allergy to azithoprine, allergy to amoxicillin, allergy to sulfa and allergy to REMICADE (MARRS # 1409USA009194). The concomitant medication was reported as flu shot in opposite arm, administered on the same day. In 2008, the patient was vaccinated with PNEUMOVAX 23, (lot number 661577/1161X expiry 06-DEC-2009) (dose, route were not reported). In 2013, the patient was vaccinated with PNEUMOVAX 23, (lot number J0007059 expiry 31-JUL-2014 date), (dose and route were not reported). In 2008 and also in 2013 (unspecified dates), the patient experienced an adverse reaction on the second day after receiving the PNEUMOVAX 23 on each occasion and the side effects included, body aches, 102 degree temperature, fatigue and general flu like symptoms that lasted for about a day. Her arm was very sore for two days. The patient experienced the same symptoms after each PNEUMOVAX 23. The outcome of 102 degree temperature, her arm was very sore, general flu like symptoms, fatigue and body aches was reported as recovered in 2008 (reported as lasted for two days). The outcome of 102 degree temperature, her arm was very sore, general flu like symptoms, fatigue, and body aches was reported as recovered in 2013 (reported as lasted for two days). Additional information has been requested.
Age: 38.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Vaccine positive rechallenge
Clinical narrative: This spontaneous report as received from a consumer refers to a 38 year old female patient with colitis, suppressed immune system, allergy to FLAGYL, allergy to azithoprine, allergy to amoxicillin, allergy to sulfa and allergy to REMICADE (MARRS # 1409USA009194). The concomitant medication was reported as flu shot in opposite arm, administered on the same day. In 2008, the patient was vaccinated with PNEUMOVAX 23, (lot number 661577/1161X expiry 06-DEC-2009) (dose, route were not reported). In 2013, the patient was vaccinated with PNEUMOVAX 23, (lot number J0007059 expiry 31-JUL-2014 date), (dose and route were not reported). In 2008 and also in 2013 (unspecified dates), the patient experienced an adverse reaction on the second day after receiving the PNEUMOVAX 23 on each occasion and the side effects included, body aches, 102 degree temperature, fatigue and general flu like symptoms that lasted for about a day. Her arm was very sore for two days. The patient experienced the same symptoms after each PNEUMOVAX 23. The outcome of 102 degree temperature, her arm was very sore, general flu like symptoms, fatigue and body aches was reported as recovered in 2008 (reported as lasted for two days). The outcome of 102 degree temperature, her arm was very sore, general flu like symptoms, fatigue, and body aches was reported as recovered in 2013 (reported as lasted for two days). Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unkown age and gender. On 12-AUG-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 12-AUG-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscular which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist refers to unspecified number of patients younger than 50 years of age and unknown gender. No medical history or concurrent conditions reported. On unknown dates, the unspecified number of patients were vaccinated with ZOSTAVAX, (dose, dose number, strength and lot number not provided). Co-suspect or concomitant therapies were not provided. The patients who received the doses were younger than 50 years of age, closer to 30 years of age. No adverse effects reported. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a nurse practitioner refers to a patient of unknown age and gender. Medical history was not reported. The nurse practitioner informed that on 28-AUG-2014 the patient was vaccinated with PROQUAD (Merck) injection, 0.5 ml, subcutaneous, which expired on 22-AUG-2014 (lot number were not reported). No adverse effects were reported. The outcome of the event was unknown. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 13-AUG-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J0112725, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 13.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a 13 year old patient of unknown gender. Patient's concurrent conditions and relevant medical history was unknown. On 26-AUG-2014 the patient was vaccinated with GARDASIL (dose and route unspecified) (lot number: J010668 with expiry date of 29-APR-2016) in the left arm. Concomitant medications were unknown. The nurse stated that refrigerator temp were out of range from 19-AUG-2014 to 26-AUG-2014. All vaccines were viable. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with GARDASIL was not reported. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 31-JUL-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: M
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: This spontaneous report as received from a medical assistant refers to a male patient of unknown age. The patient's pertinent medical history, drug reactions/allergies were not provided. On an unknown date, the patient was vaccinated with a dose of GARDASIL, (dose, route, lot # and expiration date were not provided). Co-suspect therapy and concomitant medications were not provided. It was reported that patient fainted shortly after receiving the GARDASIL vaccine on unspecified date. It was unknown which injection (in a series of three) the fainting was occurred. The patient was assisted back to an upright position and had no additional side effects. No treatment was given for the event, At the time of the report, the patient's outcome and the relatedness between the event and suspect therapy were unknown. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 12-AUG-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from  the same source. Additional information has been requested.
Sex: F
Vaccine: PPV
Symptoms: Cellulitis
Clinical narrative: This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On an unknown date the patient was vaccinated with PNEUMOVAX 23 (lot#, strength, dosage, route unknown). On an unknown date the patient developed cellulitis. The outcome of cellulitis was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. On 14-AUG-2014, the patient was vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. On 12-AUG-2014, the patient was vaccinated with GARDASIL (0.5 ml, lot# J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. On 04-JUN-2014, the patient was vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 31.0
Sex: M
Vaccine: FLU3
Symptoms: Diarrhoea, Urinary tract pain, Vomiting
Clinical narrative: Patient experienced vomiting, diarrhea, sharp urinary pain. Lasted 24-36 hours without any medical treatment.
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site rash, Local reaction
Clinical narrative: On an unknown date the patient was vaccinated with PNEUMOVAX 23 (lot#, strength, dosage and route unknown). On an unknown date the patient experienced local site reaction erythema, rash. The outcome of the event was unkonwn. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 14-AUG-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot # J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. On 07-AUG-2014, the patient was vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 41.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Musculoskeletal pain, Musculoskeletal stiffness, Vaccination site induration
Clinical narrative: Hardness at site of vaccination within a few hours of administration and shoulder pain. Now with neck stiffness (onset 9/22) which is the cause for her report. No fever.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. On 24-JUN-2014, the patient was vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 81.0
Sex: M
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist regarding a 81 year old male patient. There was no information on pertinent medical history and drug reactions or allergies. On 05-SEP-2014, the patient was vaccinated with expired dose of PNEUMOVAX 23 dose 0.5 ml (millilitre), product lot # J004747, expiry date: 20-JUL-2014 intramuscularly. There was no information on concomitant therapy. Potency of dose supported. No adverse effects was experienced by patient. The patient did not seek any medical attention. There was no product quality complaint involved. The outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: HIBV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. Information about concurrent conditions, concomitant medication and medical history was not provided. On an unknown date, the unspecified number of patients were vaccinated with improperly stored LIQUID PEDVAXHIB (lot#, dose, route and frequency were not provided). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 68.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Patient developed large red, hot area on upper left arm down towards inner elbow. No treatment needed.
Sex: U
Vaccine: RV5
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. Information about concurrent conditions, concomitant medication and medical history was not provided. On an unknown date, the unspecified number of patients were vaccinated with improperly stored ROTATEQ (lot#, dose and frequency were not provided) orally. No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 12-SEP-2014, the patient was vaccinated with PNEUMOVAX 23 lot # J007060, expiration date 28-AUG-2014, 0.5 ml, subcutaneous. Secondary and concomitant therapies were not reported. On 12-SEP-2014, the patient was inadvertently administered PNEUMOVAX 23 that had expired in 28-AUG-2014. No adverse effects reported. Additional information is not expected because the reported do not want to be contacted.
Sex: U
Vaccine: VARZOS
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 09-SEP-2014, the patient was vaccinated with ZOSTAVAX lot # J002777, expiration date 07-JUN-2014 (dose, strength, frequency and route were not reported). Secondary and concomitant therapies were not reported. On 09-SEP-2014, the patient was mistakenly administered an expired dose of ZOSTAVAX. No adverse effect reported. Additional information has been requested.
Age: 16.0
Sex: M
Vaccine: MMRV
Symptoms: Drug administered to patient of inappropriate age, Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report was received from a register nurse concerning a 16 year old male patient. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with two doses of (oka-merck) PROQUAD (dose, dose number, lot number, expiration date and route were not reported). Co-suspect and concomitant therapies were not reported. Register nurse reported that while in another state, a 16 year old male patient was given a (oka-merck) PROQUAD twice, one month apart. No adverse effects were noted. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No pertinent medical history or drug reactions/allergies were provided. The registered nurse reported that improperly stored GARDASIL INJ was administered to unspecified number of patient (dose, route and lot number not provided), (dates unspecified). No adverse effects were reported. This case is linked to case MARRS # 1409USA010731 (same reporter link). Additional information is not expected because there was no consent to follow up.
Sex: U
Vaccine: RV5
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No pertinent medical history or drug reactions/allergies were provided. The registered nurse reported that improperly stored ROTATEQ was administered to unspecified number of patients, orally (dose and lot number not provided), (dates unspecified). No adverse effects were reported. This case is linked to case MARRS # 1409USA010502 (same reporter link). Additional information is not expected because there was no consent to follow up.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. Information about concurrent conditions, concomitant medication and medical history was not provided. On an unknown date, the unspecified number of patients were vaccinated with improperly stored GARDASIL (lot#, route and frequency were not provided). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Hypokinesia, Myalgia
Clinical narrative: This spontaneous report was received from a consumer and refers to herself as female patient of unknown demographics. No pertinent medical history reported. On an unknown date in August 2014 (also reported as about two weeks ago) the patient was vaccinated with ZOSTAVAX 1 single shot (dose number and route of administration unknown) (lot number not reported). No concomitant medications reported. On an unknown date in August 2014, after receiving ZOSTAVAX the patient experienced severe local reaction to her entire upper arm. On an unknown date in August 2014 (4 and a half days later) the patient experienced she couldn't move due to extreme joint and muscle pain. The outcome of couldn't move due to extreme joint and muscle pain and experienced a severe local reaction to my entire upper arm was reported as not recovered/not resolved. The causality for the events was unknown. Additional information has been requested.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Local reaction, Mobility decreased, Myalgia
Clinical narrative: This spontaneous report was received from a consumer and refers to herself as female patient of unknown demographics. No pertinent medical history reported. On an unknown date in August 2014 (also reported as about two weeks ago) the patient was vaccinated with ZOSTAVAX 1 single shot (dose number and route of administration unknown) (lot number not reported). No concomitant medications reported. On an unknown date in August 2014, after receiving ZOSTAVAX the patient experienced severe local reaction to her entire upper arm. On an unknown date in August 2014 (4 and a half days later) the patient experienced she couldn't move due to extreme joint and muscle pain. The outcome of couldn't move due to extreme joint and muscle pain and experienced a severe local reaction to my entire upper arm was reported as not recovered/not resolved. The causality for the events was unknown. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Zostavax (Shingles) 19400UNT  INJ Redness, soreness, swelling and itching. Size of red area is currently 3 1/2" long and 2 1/2" wide on upper arm. Site is very hard from swelling and aches. There is itching as well. Today's date is 9/23/2014.
Age: 25.0
Sex: M
Vaccine: HPV4
Symptoms: Asthenia, Cardiac function test normal, Chest discomfort, Computerised tomogram head normal, Dry skin
Clinical narrative: Paresthesia, hand and foot tingling, sudden severe panic attacks, nausea, chest tightness, neck pain, headache, fatigue, dry cracked skin, fingernail abnormalities, weakness... All random and progressive. Continue to present. Facial and left arm parenthesis presented 2 months after first shot, then constant symptoms noted above after second shot. Third shot presented worsening of symptoms to present to include itchy skin, peeling skin, skin reactions, constant cold/flu like symptoms, night sweats, Reynaulds syndrome.
Age: 25.0
Sex: M
Vaccine: HPV4
Symptoms: Fatigue, Full blood count normal, Headache, Influenza like illness, Metabolic function test normal
Clinical narrative: Paresthesia, hand and foot tingling, sudden severe panic attacks, nausea, chest tightness, neck pain, headache, fatigue, dry cracked skin, fingernail abnormalities, weakness... All random and progressive. Continue to present. Facial and left arm parenthesis presented 2 months after first shot, then constant symptoms noted above after second shot. Third shot presented worsening of symptoms to present to include itchy skin, peeling skin, skin reactions, constant cold/flu like symptoms, night sweats, Reynaulds syndrome.
Age: 25.0
Sex: M
Vaccine: HPV4
Symptoms: Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats
Clinical narrative: Paresthesia, hand and foot tingling, sudden severe panic attacks, nausea, chest tightness, neck pain, headache, fatigue, dry cracked skin, fingernail abnormalities, weakness... All random and progressive. Continue to present. Facial and left arm parenthesis presented 2 months after first shot, then constant symptoms noted above after second shot. Third shot presented worsening of symptoms to present to include itchy skin, peeling skin, skin reactions, constant cold/flu like symptoms, night sweats, Reynaulds syndrome.
Age: 25.0
Sex: M
Vaccine: HPV4
Symptoms: Nuclear magnetic resonance imaging, Panic attack, Paraesthesia, Pruritus, Raynaud's phenomenon
Clinical narrative: Paresthesia, hand and foot tingling, sudden severe panic attacks, nausea, chest tightness, neck pain, headache, fatigue, dry cracked skin, fingernail abnormalities, weakness... All random and progressive. Continue to present. Facial and left arm parenthesis presented 2 months after first shot, then constant symptoms noted above after second shot. Third shot presented worsening of symptoms to present to include itchy skin, peeling skin, skin reactions, constant cold/flu like symptoms, night sweats, Reynaulds syndrome.
Age: 25.0
Sex: M
Vaccine: HPV4
Symptoms: Skin exfoliation, Skin reaction, Thyroid function test normal, Ultrasound abdomen normal
Clinical narrative: Paresthesia, hand and foot tingling, sudden severe panic attacks, nausea, chest tightness, neck pain, headache, fatigue, dry cracked skin, fingernail abnormalities, weakness... All random and progressive. Continue to present. Facial and left arm parenthesis presented 2 months after first shot, then constant symptoms noted above after second shot. Third shot presented worsening of symptoms to present to include itchy skin, peeling skin, skin reactions, constant cold/flu like symptoms, night sweats, Reynaulds syndrome.
Age: 56.0
Sex: M
Vaccine: FLUX
Symptoms: Back pain, Headache, Joint stiffness, Pyrexia
Clinical narrative: Headache, fever, stiff hips, lower and upper back pain.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Death
Clinical narrative: This medically confirmed report (initial receipt 19-Sep-2014) concerns a 63-year-old male patient. The patient recently underwent a surgery for aortic aneurysm excision (exact date unknown). It was unknown whether the patient received any other medications or immunizations. If the patient received anything else, it would have been outside the facility. On 17-Sep-2014, the patient received intramuscular AFLURIA injection (batch number T56805) at 0.5 ml annually. On 18-Sep-2014, approximately 12 hours after vaccination, the patient passed away. The cause of death was unknown. It was believed that no autopsy would be performed. The outcome was reported as 'death'. Reporter's comments: The reporter assessed the causality as serious and unlikely due to AFLURIA.
Age: 51.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Injection site pain, Injection site swelling, Tenderness
Clinical narrative: Pt called stating that she has mild swelling & pain at Adacel injection site. Pt was unable to come into clinic at this time so pt sent a photo of injection site to my cell phone. Myself & FNP looked at photo & did not see anything out of the ordinary. Pt stated that she would go f/u with clinic or go to the hospital if it got worse. Pt did not go to hospital even though symptoms got worse. Pt call back on 9/15/14 & was able to come into the clinic at 3p. Pt was seen by Dr in the clinic at this time. Pt c/o L arm swollen, red, & tender. No forearm swelling. No fever, nausea, or chills. Pt was prescribed Meloxicam Tablet, 15 MG, 1 tablet, orally, once a day, 30 day(s), 30, Refills 0 & Clindamycin HCl Capsule, 150 MG, as directed, orally, three times per day, 21 days. Dr notes: immunization reaction vs cellulitis. Will place on nsaid, 7 day course of clindamycin (PCN resistance), cool soaks. Call if sxs worsen or do not improve over next several days.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Asthma, Condition aggravated
Clinical narrative: REPORTED THAT PT HAD STARTED HAVING ASTHMA ATTACK. PT WENT TO ER FOR EVALUATION AT HOSPITAL.
Age: 0.16
Sex: F
Vaccine: DTAP, HEP, HIBV, PNC, RVX
Symptoms: Chest X-ray, Pyrexia, Screaming, Urinary tract infection, Urine analysis abnormal
Clinical narrative: 103° fever, screaming.
Age: 76.0
Sex: F
Vaccine: PPV
Symptoms: Pneumonia
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 76 year old female patient with no drug reactions/allergies. No pertinent medical history was provided. On an unspecified date in 2001, the patient was vaccinated with the first dose of PNEUMOVAX 23 (dose, route and lot number not provided) and, on an unspecified date in 2007, the patient was vaccinated with the second dose of PNEUMOVAX 23 (dose, route and lot number not provided). No co-suspect or concomitant therapies were provided. The pharmacist reported that on an unspecified date in August 2014, the patient developed pneumonia and was admitted to a hospital for the pneumonia on an unspecified date in August 2014. The patient recovered from pneumonia on an unspecified date in 2014, and was discharged from the hospital on an unspecified date in 2014. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Burning sensation, Injection site pain, Neck pain
Clinical narrative: Left shoulder pain that radiated to her anterior neck. Patient states that it was sharp and burning. She was treated with Ibuprofen 600 mg three times daily and instructed to put ice on the area of discomfort three times a day.
Age: 25.0
Sex: M
Vaccine: ANTH
Symptoms: Cardiac enzymes, Chest pain, Electrocardiogram normal, Full blood count, Neck pain
Clinical narrative: PATIENT STATES THAT HE HAD THE VACCINE 1.5HRS BEFORE SYMPTOMS. PATIENT COMPLAINED OF CHEST PAIN/NECK PAIN 8/10. NO REDNESS/TENDERNESS AT THE INJECTION SITE AND NO OTHER SYMPTOMS.   MONITORED PATIENT TORADOL 60MG FOR PAIN EKG PERFORMED/LABS DRAWN. PATIENT WAS RELEASED WITH IBUPROFEN PO 800MG AND INSTURCTED TO F/U WITH CLINIC IN 24HRS OR IF SYMPTOMS RETURN.   PROVIDER STATED IN NOTE THAT THE PATIENTS CHEST PAIN WAS LIKELY RELATED TO MILD PERICARDITIS AFTER ADMINISTRATION OF THE ANTHRAX VACCINE.
Age: 25.0
Sex: M
Vaccine: ANTH
Symptoms: Pericarditis
Clinical narrative: PATIENT STATES THAT HE HAD THE VACCINE 1.5HRS BEFORE SYMPTOMS. PATIENT COMPLAINED OF CHEST PAIN/NECK PAIN 8/10. NO REDNESS/TENDERNESS AT THE INJECTION SITE AND NO OTHER SYMPTOMS.   MONITORED PATIENT TORADOL 60MG FOR PAIN EKG PERFORMED/LABS DRAWN. PATIENT WAS RELEASED WITH IBUPROFEN PO 800MG AND INSTURCTED TO F/U WITH CLINIC IN 24HRS OR IF SYMPTOMS RETURN.   PROVIDER STATED IN NOTE THAT THE PATIENTS CHEST PAIN WAS LIKELY RELATED TO MILD PERICARDITIS AFTER ADMINISTRATION OF THE ANTHRAX VACCINE.
Age: 31.0
Sex: F
Vaccine: HEP
Symptoms: Activities of daily living impaired, Mobility decreased, Muscular weakness, Pain in extremity, Tendonitis
Clinical narrative: When I woke up, my arm felt dead. I could not lift it, it was painful, and very weak. After a month, I still did not have full movement. I went to my doctor, and he stated that the vacine had given me tendonitis in my shoulder. It has been three months and I am still in daily pain, and cannot lift or workout as I use to.
Age: 15.0
Sex: M
Vaccine: FLU3
Symptoms: Blood test, Headache, Muscle spasms, Muscular weakness, Nasal congestion
Clinical narrative: Severe headache, muscle spasms in lower back, weakness in legs, running nose combined with congestion.  Soreness particularly in the arm in which the dose was administered, beginning the following day.
Age: 15.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity, Rhinorrhoea
Clinical narrative: Severe headache, muscle spasms in lower back, weakness in legs, running nose combined with congestion.  Soreness particularly in the arm in which the dose was administered, beginning the following day.
Age: 28.0
Sex: M
Vaccine: HEPAB
Symptoms: Hypoaesthesia, Local swelling, Myalgia, Pain
Clinical narrative: Pain 8.5/10. c/o muscle aches, numbness to fingers and swelling to arm. Went to MD on 9-19-14; Dr. noted visual swelling from deltoid to elbow.
Age: 23.0
Sex: F
Vaccine: FLU3
Symptoms: Neck pain
Clinical narrative: Sore neck from back to front on right side. Subsided Sunday 9/21/14 in PM after beginning Friday 9/19/14 AM. No treatment.
Age: 6.0
Sex: F
Vaccine: FLUN4
Symptoms: Bordetella test negative, Chest X-ray abnormal, Cough, Dyspnoea, Lung hyperinflation
Clinical narrative: Cough, difficulty breathing.
Age: 6.0
Sex: F
Vaccine: FLUN4
Symptoms: Polymerase chain reaction
Clinical narrative: Cough, difficulty breathing.
Age: 74.0
Sex: M
Vaccine: FLU3
Symptoms: Dysgeusia, Immediate post-injection reaction
Clinical narrative: Immediately following administration of High Dose Flu the patient complained of a metallic taste in his mouth. This lasted for 20 minutes and then went away.
Age: 21.0
Sex: F
Vaccine: FLU4
Symptoms: Grip strength decreased, Hypoaesthesia, Neck pain, Pain in extremity, Paraesthesia
Clinical narrative: R- arm/neck (R-side) stabbing pain and unable to grip anything with R-hand.  Fingers went numb and tingly.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Fall, Loss of consciousness, Syncope
Clinical narrative: Pt was standing by nurses station post vaccination, and appeared to faint, falling to floor and losing consciousness. Dr was standing there and broke pt fall. She immediately regained consciousness and was helped to and exam room. Water and vital signs were monitored. She was also given crackers by her mother. After approx 25-30 min, pt recovered sufficiently and released in mother's care.
Age: 75.0
Sex: F
Vaccine: FLU3, PPV, PPV
Symptoms: Pain
Clinical narrative: SHARP RADIATING DOWNWARD PAIN.
Age: 75.0
Sex: F
Vaccine: FLU3, PPV, PPV
Symptoms: Injection site pain
Clinical narrative: SHARP RADIATING DOWNWARD PAIN.
Age: 22.0
Sex: F
Vaccine: FLU3
Symptoms: Joint range of motion decreased, Muscle spasms, Musculoskeletal pain, Pain in extremity, Paraesthesia
Clinical narrative: Pain and cramping down left arm accompanied by some tingling. Limited range of motion due to pain in shoulder.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Miliaria, Rash, Rash erythematous, Rash macular
Clinical narrative: Pt reports flat, red, splotchy rash that appeared one hour after being administered FLUVIRIN. She also reports having a massage within hours of vaccine (prior to vaccine). Pt mentioned it looked like heat rash. Rash appeared on abdomen - under breasts to waist not appearing on back. She reported a similar rash appearing after taking ROBITUSSIN and guaifenesin.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, HIBV
Symptoms: Wrong drug administered
Clinical narrative: Patient was given a HIB vaccine vs Hepatitis B.
Age: 48.0
Sex: M
Vaccine: HEPA
Symptoms: Arthralgia, Electromyogram normal, Hypoaesthesia, Laboratory test normal, Muscle spasms
Clinical narrative: The patient developed muscle cramps, joint pain and muscle twitching.  Then developed right arm weakness and facial numbness associated with right eye visual disturbances.  Pt was seen be a neurologist and given Solumedrol x 3 doses followed by a tapering dose of prednisone.  All labs, EMG, eye exam are normal thus far.  Pt sts he was seen at hospital and is currently awaiting the results.  Pt reports symptoms have somewhat resolved.
Age: 48.0
Sex: M
Vaccine: HEPA
Symptoms: Muscle twitching, Muscular weakness, Ophthalmological examination normal, Visual impairment
Clinical narrative: The patient developed muscle cramps, joint pain and muscle twitching.  Then developed right arm weakness and facial numbness associated with right eye visual disturbances.  Pt was seen be a neurologist and given Solumedrol x 3 doses followed by a tapering dose of prednisone.  All labs, EMG, eye exam are normal thus far.  Pt sts he was seen at hospital and is currently awaiting the results.  Pt reports symptoms have somewhat resolved.
Age: 34.0
Sex: F
Vaccine: FLUX
Symptoms: Chills, Dizziness, Ear discomfort, Hyperhidrosis, Myalgia
Clinical narrative: Sore throat, dizziness, nausea, chills, sweats, muscle aches, felt like a cotton ball was in my left ear.
Age: 34.0
Sex: F
Vaccine: FLUX
Symptoms: Nausea, Oropharyngeal pain
Clinical narrative: Sore throat, dizziness, nausea, chills, sweats, muscle aches, felt like a cotton ball was in my left ear.
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Contusion, Injection site erythema, Injection site induration
Clinical narrative: Received FLUZONE HIGH DOSE vaccine on 9/9/14. She reported on 9/12/14 injection site had erythema and induration of approx 3" diameter. This had resolved when she called, except for bruising.
Age: 46.0
Sex: F
Vaccine: FLU4
Symptoms: Glossodynia, Swollen tongue, Urticaria
Clinical narrative: Had vaccine 11:30 AM 9/19/14. Developed burning of tongue shortly after. By 3:30, swelling of tongue; by evening hives. Did not seek med. attention.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Pruritus
Clinical narrative: Rash at site of injection, itching, on 9/16 felt like she was being pricked at injection site, itching seems to be getting better on 9/17. Informed patient to try hydrocortisone OTC cream for a few days then go to MD if not better.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Intense pain at injection site. Pain at rest not relieved by anything.
Age: 1.27
Sex: M
Vaccine: DTAPIPVHIB, FLU3, VARCEL
Symptoms: Injection site erythema
Clinical narrative: Redness at site.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: 2 x 4 in raised and red site reaction.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site nerve damage
Clinical narrative: Patient alleged nerve damage to shoulder at location of injection.
Age: 68.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site pain, Injection site rash
Clinical narrative: Rash of upper left arm. Pain of upper left arm.
Age: 91.0
Sex: M
Vaccine: FLU3
Symptoms: Pain, Vomiting
Clinical narrative: Patient had aches and pains and one episode of vomiting the evening of having the Fluzone HD vaccine administered.
Age: 66.0
Sex: F
Vaccine: FLUX
Symptoms: Pain in extremity, Pyrexia, Rash
Clinical narrative: Sore arms, fever, rash.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Noticed quarter sized redness to injection site in the morning upon waking, progressed to about 6cm diameter indurated area with warmth to touch by the afternoon.
Age: 17.0
Sex: M
Vaccine: HPV4
Symptoms: Clonus, Dizziness, Pallor, Syncope
Clinical narrative: Fainting with clonic jerks, pale, woke almost immediately but pale/woozy x 20 mins.
Age: 18.0
Sex: M
Vaccine: TDAP
Symptoms: Posture abnormal, Pupil fixed, Speech disorder, Staring, Tremor
Clinical narrative: Patient was conversing normally, then word faded out in mid-speech and patient leaned left until head came to rest on padded exam table. Bilateral pupils noted to be dilated with fixed stare straight ahead, mild tremors noted to all 4 extremities lasting 20 to 30 seconds.  Then all tremors ceased, pupils returned to normal, patient sat self up and asked "what happened?".  Student alert and oriented x person, place, and time. Respirations remained even and unlabored before, during, and after event.  Patient denies any previous seizure history of any type at this time.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Immediate post-injection reaction, Injection site pruritus, Injection site warmth, Swelling
Clinical narrative: Severe swelling immediately, size of tennis ball, tightness in my throat, itching at injection site, very hot to touch, dizziness, mild tachycardia.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Tachycardia, Throat tightness
Clinical narrative: Severe swelling immediately, size of tennis ball, tightness in my throat, itching at injection site, very hot to touch, dizziness, mild tachycardia.
Age: 66.0
Sex: M
Vaccine: FLUN4
Symptoms: Fatigue
Clinical narrative: Moderate to extreme fatigue continues.
Age: 77.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Patient noticed swelling at injection site 09/19 in PM, redness appeared larger next day and moved to side of injection site, on 09/21 redness and swelling spread down to bicep and experienced fever and chills, on 9/22 reaction started to dissipate and on 09/23 almost gone-patient used ice and Tylenol and Claritin to treat.
Age: 67.0
Sex: F
Vaccine: DTAP
Symptoms: Arthralgia, Injection site pain, Myalgia
Clinical narrative: Arthralgia and myalgia, diffuse and mod severe, no fever, +pain at injection site (unable to lie on that arm x 3 days). No fever. No redness.
Age: 67.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Chills, Feeling abnormal, Listless, Muscle spasms
Clinical narrative: Muscle pains; muscle cramps; head feels like it is stuffed with cotton; chills; weakness/listlessness.
Age: 67.0
Sex: M
Vaccine: FLU3
Symptoms: Myalgia
Clinical narrative: Muscle pains; muscle cramps; head feels like it is stuffed with cotton; chills; weakness/listlessness.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain, Mobility decreased, Musculoskeletal pain, Musculoskeletal stiffness, Neck pain
Clinical narrative: Extremely sore shoulder arm and neck stiffness difficulty to turn head with pain coming from shot area up thru arm to neck.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Extremely sore shoulder arm and neck stiffness difficulty to turn head with pain coming from shot area up thru arm to neck.
Age: 3.0
Sex: F
Vaccine: FLUX
Symptoms: Blood test, Bruxism, Excessive eye blinking, Grimacing, Muscle contractions involuntary
Clinical narrative: Tic disorder; "Cringing", clenched jaw, hands balled into fists, excessive blinking, grimacing. Disorder changes in frequency. At it's worst, it occurs every 15 seconds. At best, a few times per/day & will sometimes disappear for weeks at a time. The disorder has continued off & on for almost a year.
Age: 3.0
Sex: F
Vaccine: FLUX
Symptoms: Neurological examination, Tic, Urine analysis
Clinical narrative: Tic disorder; "Cringing", clenched jaw, hands balled into fists, excessive blinking, grimacing. Disorder changes in frequency. At it's worst, it occurs every 15 seconds. At best, a few times per/day & will sometimes disappear for weeks at a time. The disorder has continued off & on for almost a year.
Age: 69.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site swelling
Clinical narrative: Injection site arm swelling from shoulder to elbow. Patient went to doctor to seek treatment and received a steroid injection to reduce swelling.
Age: 54.0
Sex: M
Vaccine: FLUX
Symptoms: Injected limb mobility decreased, Musculoskeletal pain, Periarthritis, Tenderness
Clinical narrative: I started getting a sore shoulder.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Dry skin, Erythema, Pruritus, Swelling face
Clinical narrative: Husband called on 9/10/14 at 1:44PM to notify us that his wife had a reaction to the flu shot a few hours after it was administered (approx. 3pm 9/9/14). She reports that she had some itching and today reports a mild puffy face. Pharmacist followed up with wife on 9/12/14 she reported that her symptoms have improved somewhat - at that time she had puffy dry red itchy face that goes down to her upper neck. She had been taking Benadryl on her own accord.